Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral processes for next-generation cell therapies. CAMBRIDGE, Mass. and SAN DIEGO, Calif. — Kytopen Corp., a leader in continuous flow cellular engineering, and Excellos, Inc., a cell therapy CDMO and member of Blood Centers of America (BCA), today announced that the two […]
Company initiates search for successor ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that Chief Financial Officer Douglas Swirsky has informed the Company of his decision to transition from his role in the first […]
Landmark dataset aims to transform understanding of immune-driven illness and accelerate drug discovery SAN FRANCISCO & SEATTLE — Third Rock Ventures and Parse Biosciences today announced a strategic collaboration to create an unprecedented atlas of 5 million T cell receptors (TCRs) using Parse Biosciences’ GigaLab platform. The project is led by a stealth Third Rock […]
Schlieren, Switzerland — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire DOPPL SA, a Lausanne-based innovator in the organoid space, including the Sun Bioscience Gri3D® technology. The acquisition strengthens InSphero’s position as the most comprehensive provider of advanced 3D in vitro models, combining scalable spheroid and organoid technologies with integrated assay […]
Framingham, MA – Ensorcell, the newest company to emerge from Re:Build Manufacturing, has officially launched operations in Framingham, Massachusetts. Ensorcell evaluates critical research and bioprocess technologies to develop innovative, intuitive and cost-effective solutions. Research, development and manufacturing are all United States-based, drawing from the vast network of cross-sector engineering and operations expertise in the Re:Build Manufacturing ecosystem. “At Re:Build […]
LONDON — SMi Systems, a leading innovator in single-molecule detection for drug discovery and diagnostics, announces the appointment of Ron Andrews, Founder and Managing Partner of Bethesda Group Advisors, to its Board of Directors as a Non-Executive Director. During more than 35 years of strategic leadership in the Life Sciences Tools and Molecular Diagnostics sectors, Mr Andrews […]
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Mary Blenn has been appointed to the newly created role of Executive Vice President and Chief Operating Officer, effective immediately. Ms. Blenn will report to President and CEO […]
Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end […]
Hamburg Germany — acCELLerate, a manufacturer of assay-ready frozen cells has established an agreement with ATCC a global biological resource and standards organization. Under the agreement, acCELLerate will produce custom cell banks from ATCC cell lines for research clients in the pharmaceutical and biotechnology industry. This collaboration combines ATCC’s internationally recognized portfolio of high-quality, authenticated […]
Rockville, MD — OriGene Technologies, a global leader in gene-centric research tools, today announced an exclusive distributorship and a co-marketing partnership with Nanoportal Biotech for ProteanFect™, an industry-first, coacervate-based gene delivery reagent that promises to redefine transfection in challenging cell types. ProteanFect represents a major leap forward in nucleic acid delivery. Unlike conventional lipid- or polymer-based […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
